Alzamend Neuro, Inc.
ALZN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677077
In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Alzamend Neuro, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 11 | 17 | +6 |
| Shares | 295.7K | 645.0K | +349.3K (+118.1%) |
| Value | $2.58M | $1.99M | −$596.0K (−23.1%) |
New holders (11)
Institutions that held Alzamend Neuro, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 172,913 | $533.0K | 0.00% |
| Sassicaia Capital Advisers LLC | 93,762 | $289.0K | 0.82% |
| Qube Research & Technologies Ltd | 50,852 | $157.0K | 0.00% |
| Citadel Advisors LLC | 45,225 | $139.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 31,600 | $97.0K | 0.00% |
| Warberg Asset Management LLC | 14,000 | $43.0K | 0.01% |
| Group One Trading, L.P. | 6,710 | $21.0K | 0.00% |
| Cutler Group LP | 5,000 | $15.0K | 0.00% |
| JPMorgan Chase & Co | 871 | $3.00K | 0.00% |
| Harbor Investment Advisory, LLC | 815 | $3.00K | 0.00% |
| Allworth Financial LP | 300 | $1.00K | 0.00% |
Sold out (5)
Institutions that held Alzamend Neuro, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Geode Capital Management, LLC | 44,600 | $389.0K |
| Two Sigma Securities, LLC | 16,018 | $140.0K |
| Virtu Financial LLC | 15,402 | $135.0K |
| Wells Fargo & Company | 193 | $2.00K |
| Advisor Group Holdings, Inc. | 27 | $0 |